Pro-Dex (Nasdaq:PDEX) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

PDEX Stoklara Genel Bakış

Pro-Dex, Inc. dünya çapında tıbbi cihaz orijinal ekipman üreticileri için elektrikli cerrahi aletler tasarlar, geliştirir, üretir ve satar.

Şirket hakkında

PDEX temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	3/6
Geçmiş Performans	0/6
Finansal Sağlık	5/6
Temettüler	0/6

Ödüller

Trading at 26.9% below our estimate of its fair value

Earnings are forecast to grow 42.82% per year

Risk Analizi

Finansal sonuçları etkileyen büyük tek seferlik kalemler

Profit margins (4%) are lower than last year (15.3%)

Pro-Dex, Inc. Rakipler

Sensus Healthcare

NasdaqCM:SRTS

US$95.1m

Kewaunee Scientific

NasdaqGM:KEQU

US$95.6m

Semler Scientific

NasdaqCM:SMLR

US$164.7m

Electromed

NYSEAM:ELMD

US$185.5m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Pro-Dex
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$31.34
52 Haftanın En Yüksek Seviyesi	US$31.95
52 Haftanın En Düşük Seviyesi	US$14.51
Beta	0.38
11 Aylık Değişim	34.33%
3 Aylık Değişim	82.95%
1 Yıllık Değişim	100.26%
33 Yıllık Değişim	21.47%
5 Yıllık Değişim	123.06%
Halka arzdan bu yana değişim	476.36%

Son Haberler & Güncellemeler

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Sep 10

Recent updates

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Sep 10

Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jan 24

Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

May 20

Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Oct 05

Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting

Sep 26

When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Sep 20

Pro-Dex GAAP EPS of $0.38, revenue of $12.61M

Aug 25

Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

May 10

Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Apr 21

Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Mar 14

Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

Feb 09

We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Nov 17

Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Aug 29

A History Of Strong Growth Rates: Pro-Dex On Sale

Aug 25

The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

May 18

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Mar 29

Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 15

The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Feb 26

Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

Feb 13

We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Feb 08

Pro-Dex EPS misses by $0.27, misses on revenue

Feb 04

Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

Jan 25

What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?

Jan 11

How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?

Dec 28

With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting

Dec 14

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Nov 30

Hissedar Getirileri

	PDEX	US Medical Equipment	US Pazar
7D	17.8%	-0.6%	-0.4%
1Y	100.3%	22.6%	34.1%

Getiri vs. Endüstri: PDEX exceeded the US Medical Equipment industry which returned 22.3% over the past year.

Getiri vs Piyasa: PDEX exceeded the US Market which returned 33.4% over the past year.

Fiyat Oynaklığı

Is PDEX's price volatile compared to industry and market?
PDEX volatility
PDEX Average Weekly Movement	9.3%
Medical Equipment Industry Average Movement	8.5%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: PDEX's share price has been volatile over the past 3 months.

Zaman İçindeki Volatilite: PDEX's weekly volatility (9%) has been stable over the past year.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1978	147	Rick Van Kirk	www.pro-dex.com

Pro-Dex, Inc. dünya çapında tıbbi cihaz orijinal ekipman üreticileri için elektrikli cerrahi aletler tasarlar, geliştirir, üretir ve satar. Şirket, öncelikle ortopedik, torasik ve kraniyomaksillofasiyal pazarlarda kullanılan otoklavlanabilir, pille çalışan ve elektrikli ve çok işlevli cerrahi sürücüler ve tıraş makineleri sunmaktadır. Ayrıca mühendislik, kalite ve düzenleyici danışmanlık hizmetleri sağlar; ve çeşitli endüstrilere döner hava motorları üretir ve satar.

Pro-Dex, Inc. Temel Bilgiler Özeti

Pro-Dex'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PDEX temel i̇stati̇sti̇kler
Piyasa değeri	US$100.24m
Kazançlar(TTM)	US$2.13m
Gelir(TTM)	US$53.84m

49.5x

F/K Oranı

2.0x

P/S Oranı

PDEX aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PDEX gelir tablosu (TTM)
Gelir	US$53.84m
Gelir Maliyeti	US$39.29m
Brüt Kâr	US$14.55m
Diğer Giderler	US$12.42m
Kazançlar	US$2.13m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.63
Brüt Marj	27.02%
Net Kâr Marjı	3.95%
Borç/Özkaynak Oranı	38.6%

PDEX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

PDEX Stoklara Genel Bakış

Ödüller

Risk Analizi

Pro-Dex, Inc. Rakipler

NasdaqCM:SRTS

US$95.1m

NasdaqGM:KEQU

US$95.6m

NasdaqCM:SMLR

US$164.7m

NYSEAM:ELMD

US$185.5m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 16%

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Price target increased by 7.1% to US$30.00

New major risk - Revenue and earnings growth

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Recent updates

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 16%

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Price target increased by 7.1% to US$30.00

New major risk - Revenue and earnings growth

Full year 2024 earnings: EPS and revenues exceed analyst expectations

The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

Consensus EPS estimates fall by 32%

Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

New minor risk - Earnings quality

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investor sentiment improves as stock rises 16%

Price target increased by 7.7% to US$28.00

Pro-Dex, Inc., Annual General Meeting, Dec 14, 2023

Pro-Dex, Inc. announced delayed annual 10-K filing

Investor sentiment improves as stock rises 17%

Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 15%, revenue upgraded

Price target decreased by 16% to US$26.00

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Pro-Dex, Inc. Announces Board Elections

Insufficient new directors

First quarter 2023 earnings released: EPS: US$0.30 (vs US$0.29 in 1Q 2022)

Insufficient new directors

Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Pro-Dex, Inc., Annual General Meeting, Nov 17, 2022

Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting

Investor sentiment deteriorated over the past week

When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Full year 2022 earnings released: EPS: US$1.06 (vs US$1.17 in FY 2021)

Pro-Dex GAAP EPS of $0.38, revenue of $12.61M

Now 21% undervalued

Consensus EPS estimates fall by 27%

Price target decreased to US$30.00

Independent Director recently bought US$58k worth of stock

Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Investor sentiment improved over the past week

Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Investor sentiment deteriorated over the past week

Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Price target decreased to US$34.00

We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

First quarter 2022 earnings released: EPS US$0.29 (vs US$0.33 in 1Q 2021)

Independent Director recently bought US$85k worth of stock

Investor sentiment deteriorated over the past week

Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Full year 2021 earnings released: EPS US$1.17 (vs US$1.56 in FY 2020)

Investor sentiment deteriorated over the past week